TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer
The testis‐specific Y‐encoded‐like protein (TSPYL) gene family includes TSPYL1 to TSPYL6. We previously reported that TSPYL5 regulates cytochrome P450 (CYP) 19A1 expression. Here we show that TSPYLs, especially TSPYL 1, 2, and 4, can regulate the expression of many CYP genes, including CYP17A1, a ke...
Uloženo v:
| Vydáno v: | Clinical pharmacology and therapeutics Ročník 104; číslo 1; s. 201 - 210 |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.07.2018
|
| Témata: | |
| ISSN: | 0009-9236, 1532-6535, 1532-6535 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The testis‐specific Y‐encoded‐like protein (TSPYL) gene family includes TSPYL1 to TSPYL6. We previously reported that TSPYL5 regulates cytochrome P450 (CYP) 19A1 expression. Here we show that TSPYLs, especially TSPYL 1, 2, and 4, can regulate the expression of many CYP genes, including CYP17A1, a key enzyme in androgen biosynthesis, and CYP3A4, an enzyme that catalyzes the metabolism of abiraterone, a CYP17 inhibitor. Furthermore, a common TSPYL1 single nucleotide polymorphism (SNP), rs3828743 (G/A) (Pro62Ser), abolishes TSPYL1's ability to suppress CYP3A4 expression, resulting in reduced abiraterone concentrations and increased cell proliferation. Data from a prospective clinical trial of 87 metastatic castration‐resistant prostate cancer patients treated with abiraterone acetate/prednisone showed that the variant SNP genotype (A) was significantly associated with worse response and progression‐free survival. In summary, TSPYL genes are novel CYP gene transcription regulators, and genetic alteration within these genes significantly influences response to drug therapy through transcriptional regulation of CYP450 genes. |
|---|---|
| AbstractList | The testis-specific Y-encoded-like protein (TSPYL) gene family includes TSPYL1 to TSPYL6. We previously reported that TSPYL5 regulates cytochrome P450 (CYP) 19A1 expression. Here we show that TSPYLs, especially TSPYL 1, 2, and 4, can regulate the expression of many CYP genes, including CYP17A1, a key enzyme in androgen biosynthesis, and CYP3A4, an enzyme that catalyzes the metabolism of abiraterone, a CYP17 inhibitor. Furthermore, a common TSPYL1 single nucleotide polymorphism (SNP), rs3828743 (G/A) (Pro62Ser), abolishes TSPYL1's ability to suppress CYP3A4 expression, resulting in reduced abiraterone concentrations and increased cell proliferation. Data from a prospective clinical trial of 87 metastatic castration-resistant prostate cancer patients treated with abiraterone acetate/prednisone showed that the variant SNP genotype (A) was significantly associated with worse response and progression-free survival. In summary, TSPYL genes are novel CYP gene transcription regulators, and genetic alteration within these genes significantly influences response to drug therapy through transcriptional regulation of CYP450 genes.The testis-specific Y-encoded-like protein (TSPYL) gene family includes TSPYL1 to TSPYL6. We previously reported that TSPYL5 regulates cytochrome P450 (CYP) 19A1 expression. Here we show that TSPYLs, especially TSPYL 1, 2, and 4, can regulate the expression of many CYP genes, including CYP17A1, a key enzyme in androgen biosynthesis, and CYP3A4, an enzyme that catalyzes the metabolism of abiraterone, a CYP17 inhibitor. Furthermore, a common TSPYL1 single nucleotide polymorphism (SNP), rs3828743 (G/A) (Pro62Ser), abolishes TSPYL1's ability to suppress CYP3A4 expression, resulting in reduced abiraterone concentrations and increased cell proliferation. Data from a prospective clinical trial of 87 metastatic castration-resistant prostate cancer patients treated with abiraterone acetate/prednisone showed that the variant SNP genotype (A) was significantly associated with worse response and progression-free survival. In summary, TSPYL genes are novel CYP gene transcription regulators, and genetic alteration within these genes significantly influences response to drug therapy through transcriptional regulation of CYP450 genes. The testis‐specific Y‐encoded‐like protein (TSPYL) gene family includes TSPYL1 to TSPYL6. We previously reported that TSPYL5 regulates cytochrome P450 (CYP) 19A1 expression. Here we show that TSPYLs, especially TSPYL 1, 2, and 4, can regulate the expression of many CYP genes, including CYP17A1, a key enzyme in androgen biosynthesis, and CYP3A4, an enzyme that catalyzes the metabolism of abiraterone, a CYP17 inhibitor. Furthermore, a common TSPYL1 single nucleotide polymorphism (SNP), rs3828743 (G/A) (Pro62Ser), abolishes TSPYL1's ability to suppress CYP3A4 expression, resulting in reduced abiraterone concentrations and increased cell proliferation. Data from a prospective clinical trial of 87 metastatic castration‐resistant prostate cancer patients treated with abiraterone acetate/prednisone showed that the variant SNP genotype (A) was significantly associated with worse response and progression‐free survival. In summary, TSPYL genes are novel CYP gene transcription regulators, and genetic alteration within these genes significantly influences response to drug therapy through transcriptional regulation of CYP450 genes. |
| Author | Kohli, Manish Liu, Duan Hillman, David W. Wang, Liguo Qin, Sisi Weinshilboum, Richard M. Wang, Liewei Vedell, Peter T. Niu, Nifang Yu, Jia |
| Author_xml | – sequence: 1 givenname: Sisi surname: Qin fullname: Qin, Sisi organization: Mayo Clinic – sequence: 2 givenname: Duan surname: Liu fullname: Liu, Duan organization: Mayo Clinic – sequence: 3 givenname: Manish surname: Kohli fullname: Kohli, Manish organization: Mayo Clinic – sequence: 4 givenname: Liguo surname: Wang fullname: Wang, Liguo organization: Mayo Clinic – sequence: 5 givenname: Peter T. surname: Vedell fullname: Vedell, Peter T. organization: Mayo Clinic – sequence: 6 givenname: David W. surname: Hillman fullname: Hillman, David W. organization: Mayo Clinic – sequence: 7 givenname: Nifang surname: Niu fullname: Niu, Nifang organization: Mayo Clinic – sequence: 8 givenname: Jia surname: Yu fullname: Yu, Jia organization: Mayo Clinic – sequence: 9 givenname: Richard M. surname: Weinshilboum fullname: Weinshilboum, Richard M. organization: Mayo Clinic – sequence: 10 givenname: Liewei surname: Wang fullname: Wang, Liewei email: Wang.Liewei@mayo.edu organization: Mayo Clinic |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29027195$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kc9u1DAQxi3Uim4L4g2Qj0hVWv9J4pjbKmqh0lZEsBx6imzvpBgldrAdwd54hL4Db8aT4FVLTzPj-c0n6_tO0ZHzDhB6Q8kFJYRdmjldSCJeoBWtOCvqildHaEUIkYVkvD5BpzF-z2Mpm-YlOmGSMEFltUJ_tl-6uw2-VpMd9_gz3C-jShBxe9dRsaZYud2h5-sSX_2aA8RovXuPO5_AJatGfAvmm3I2Trj1LgWrl2TdPU4er7UNWSvkn2bhOHsXAVuXL5KKSSVrcJubzGTJv78fMmPzu0u4C_4AQN47A-EVOh7UGOH1Uz1DX6-vtu3HYvPpw0273hSmFFQUA9uZAZimzBidXZH1UDFBZGMUE6YRtNSSS12VShqAmmutpdiRmjPdDKXQ_Ay9e9Sdg_-xQEz9ZKOBcVQO_BL7bBitBOGUZPTtE7roCXb9HOykwr7_b2wGzh-Bn3aE_fOekv6QV5_z6nNefdttc-H_AAMXi3o |
| CitedBy_id | crossref_primary_10_1016_j_pharep_2019_04_011 crossref_primary_10_1186_s13148_023_01442_8 crossref_primary_10_4155_fmc_2021_0136 crossref_primary_10_1002_ajmg_a_62966 crossref_primary_10_1002_cnr2_70016 crossref_primary_10_1002_jcb_29252 crossref_primary_10_1111_jcmm_70210 crossref_primary_10_3389_fphar_2022_912618 crossref_primary_10_1038_s44276_024_00093_3 crossref_primary_10_1124_dmd_118_082164 crossref_primary_10_1111_cts_12758 crossref_primary_10_1093_ajh_hpae067 crossref_primary_10_1111_cts_13729 crossref_primary_10_1007_s00280_020_04133_w crossref_primary_10_1007_s43440_020_00133_y crossref_primary_10_1002_cpt_1692 crossref_primary_10_1002_advs_202306486 crossref_primary_10_1016_j_ijbiomac_2025_143375 crossref_primary_10_1016_j_molcel_2023_05_017 crossref_primary_10_3389_fphar_2022_833217 crossref_primary_10_1007_s12672_024_01461_8 crossref_primary_10_1111_cas_15718 crossref_primary_10_1007_s11060_020_03636_z crossref_primary_10_1124_dmd_122_000945 crossref_primary_10_3390_ijms25010039 crossref_primary_10_2217_pgs_2019_0191 crossref_primary_10_3389_fphar_2022_1047318 |
| ContentType | Journal Article |
| Copyright | 2017, The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics 2017, The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. |
| Copyright_xml | – notice: 2017, The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics – notice: 2017, The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. |
| DBID | 24P CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1002/cpt.907 |
| DatabaseName | Wiley Online Library Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1532-6535 |
| EndPage | 210 |
| ExternalDocumentID | 29027195 CPT907 |
| Genre | article Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Minnesota Partnership for Biotechnology and Medical Genomics funderid: #14.37 – fundername: Department of Defense – fundername: Prostate Cancer Foundation – fundername: National Institutes of Health funderid: U19 GM61388 ; R01 CA196648 ; R01 GM28157 – fundername: NIGMS NIH HHS grantid: R01 GM125633 – fundername: NIGMS NIH HHS grantid: U19 GM061388 – fundername: NCI NIH HHS grantid: R01 CA196648 – fundername: NIGMS NIH HHS grantid: R01 GM028157 |
| GroupedDBID | --- --K -Q- .55 .GJ 0R~ 1B1 1CY 1OB 1OC 24P 29B 33P 354 36B 39C 3O- 4.4 52O 53G 5GY 5RE 6J9 70F 8F7 AAESR AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AAQOH AAQQT AAWTL AAYCA AAYOK AAZKR ABCUV ABJNI ABLJU ABQWH ACBNA ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACPOU ACRPL ACXQS ACYXJ ADBBV ADBTR ADKYN ADNMO ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AENEX AEQDE AEUYR AFBPY AFFNX AFFPM AHBTC AI. AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BMXJE BRXPI C45 CAG COF CS3 DCZOG DPXWK DU5 EBS EE. EJD EMOBN F5P GODZA GWYGA HGLYW IH2 IHE J5H L7B LATKE LEEKS LITHE LOXES LSO LUTES LYRES M41 MEWTI N4W N9A NQ- O9- OPC OVD P2P P2W PALCI RIG RIWAO RJQFR RNTTT ROL RPZ SAMSI SEW SJN SUPJJ TEORI TWZ UHS VH1 WBKPD WH7 WOHZO WXSBR WYJ X7M Y6R YCJ YFH YOC YXB ZGI ZXP ZZTAW AGHNM CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AEYWJ AGXDD AGYGG AIDQK AIDYY |
| ID | FETCH-LOGICAL-c4717-f2dcfe2b12ccb10096f527098ca27c8714b939b54a9cee63bbb97d0632b8f47b3 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 34 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000434960300035&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0009-9236 1532-6535 |
| IngestDate | Sun Nov 09 13:17:33 EST 2025 Thu Apr 03 06:57:54 EDT 2025 Wed Jan 22 16:29:02 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Attribution-NonCommercial 2017, The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4717-f2dcfe2b12ccb10096f527098ca27c8714b939b54a9cee63bbb97d0632b8f47b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcpt.907 |
| PMID | 29027195 |
| PQID | 1951570310 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1951570310 pubmed_primary_29027195 wiley_primary_10_1002_cpt_907_CPT907 |
| PublicationCentury | 2000 |
| PublicationDate | July 2018 |
| PublicationDateYYYYMMDD | 2018-07-01 |
| PublicationDate_xml | – month: 07 year: 2018 text: July 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Clinical pharmacology and therapeutics |
| PublicationTitleAlternate | Clin Pharmacol Ther |
| PublicationYear | 2018 |
| References | 2012; 364 2013; 27 2006; 37 1998; 81 2005; 26 1982; 69 1987; 84 2010; 25 2010; 24 2006; 66 2011; 71 2015; 43 2008; 68 2001; 15 2007; 67 2014; 11 2011; 121 2004; 101 2007; 168 2010; 38 2010; 35 2002; 30 2013; 43 2000; 67 2008; 13 2004 2003 2011; 39 2016; 17 2007; 12 2004; 308 2015; 151 2004; 10 2006; 84 2007; 195 2002; 360 2015; 22 2015; 518 2013; 82 1995; 104 2016 2015 2012; 6 2012; 44 2003; 63 2003; 20 1998; 78 2011; 145 2001; 30 2009; 105 |
| References_xml | – volume: 43 start-page: 379 year: 2013 end-page: 389 article-title: A phase I, open‐label, single‐dose, mass balance study of 14C‐labeled abiraterone acetate in healthy male subjects publication-title: Xenobiotica – volume: 360 start-page: 1155 year: 2002 end-page: 1162 article-title: Clinical importance of the cytochromes P450 publication-title: Lancet – volume: 17 year: 2016 article-title: Common genetic variation in CYP17A1 and response to abiraterone acetate in patients with metastatic castration‐resistant prostate cancer publication-title: Int. J. Mol. Sci. – volume: 38 start-page: 2259 year: 2010 end-page: 2265 article-title: Evaluation of the effects of cytochrome P450 nonsynonymous single‐nucleotide polymorphisms on tanshinol borneol ester metabolism and inhibition potential publication-title: Drug Metab. Dispos. – volume: 81 start-page: 265 year: 1998 end-page: 270 article-title: Murine and human TSPYL genes: novel members of the TSPY‐SET‐NAP1L1 family publication-title: Cytogenet. Cell Genet. – volume: 30 start-page: 101 year: 2001 end-page: 119 article-title: The genetics, pathophysiology, and management of human deficiencies of P450c17 publication-title: Endocrinol. Metab. Clin. North Am. – volume: 39 start-page: 830 year: 2011 end-page: 837 article-title: Evaluation of the effects of 20 nonsynonymous single nucleotide polymorphisms of CYP2C19 on S‐mephenytoin 4′‐hydroxylation and omeprazole 5′‐hydroxylation publication-title: Drug Metab. Dispos. – volume: 27 start-page: 657 year: 2013 end-page: 670 article-title: TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression publication-title: Mol. Endocrinol. – volume: 43 start-page: D470 year: 2015 end-page: 478 article-title: The BioGRID interaction database: 2015 update publication-title: Nucleic Acids Res. – volume: 69 start-page: 553 year: 1982 end-page: 566 article-title: A Class of Rank Test Procedures for Censored Survival‐Data publication-title: Biometrika – volume: 105 start-page: 58 year: 2009 end-page: 63 article-title: Trade herbal products and induction of CYP2C19 and CYP2E1 in cultured human hepatocytes publication-title: Basic Clin. Pharmacol. Toxicol. – volume: 10 start-page: 7121 year: 2004 end-page: 7126 article-title: The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer publication-title: Clin Cancer Res. – volume: 195 start-page: 459 year: 2007 end-page: 472 article-title: Human adrenal corticocarcinoma NCI‐H295R cells produce more androgens than NCI‐H295A cells and differ in 3beta‐hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities publication-title: J Endocrinol – volume: 11 start-page: 32 year: 2014 end-page: 42 article-title: CYP17 inhibitors—abiraterone, C17,20‐lyase inhibitors and multi‐targeting agents publication-title: Nat. Rev. Urol. – volume: 22 start-page: 1353 year: 2015 end-page: 1362 article-title: TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFbeta signaling activation publication-title: Cell Death Differ. – year: 2004 – volume: 145 start-page: 787 year: 2011 end-page: 799 article-title: Analysis of the human endogenous coregulator complexome publication-title: Cell – volume: 101 start-page: 11689 year: 2004 end-page: 11694 article-title: Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 37 start-page: 82 year: 2006 end-page: 90 article-title: Identification of novel candidate genes for globin regulation in erythroid cells containing large deletions of the human beta‐globin gene cluster publication-title: Blood Cells Mol. Dis. – volume: 84 start-page: 407 year: 1987 end-page: 411 article-title: Cytochrome P450c17 (steroid 17 alpha‐hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 30 start-page: 795 year: 2002 end-page: 804 article-title: CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes publication-title: Drug Metab. Dispos. – year: 2015 – volume: 12 start-page: 440 year: 2007 end-page: 445 article-title: Orphan nuclear receptors in drug discovery publication-title: Drug Discov. Today – volume: 6 start-page: 631 year: 2012 end-page: 638 article-title: Single‐nucleotide polymorphisms in the TSPYL‐4 and NT5DC1 genes are associated with susceptibility to chronic obstructive pulmonary disease publication-title: Mol. Med. Rep. – volume: 26 start-page: 361 year: 2005 end-page: 379 article-title: Gonadotropin‐releasing hormone agonists in the treatment of prostate cancer publication-title: Endocr. Rev. – volume: 82 start-page: 453 year: 2013 end-page: 462 article-title: Bioactivities of Jc‐SCRIP, a type 1 ribosome‐inactivating protein from Jatropha curcas seed coat publication-title: Chem. Biol. Drug Des. – volume: 35 start-page: 476 year: 2010 end-page: 489 article-title: The histone shuffle: histone chaperones in an energetic dance publication-title: Trends Biochem. Sci. – volume: 68 start-page: 4447 year: 2008 end-page: 4454 article-title: Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration‐resistant tumor growth publication-title: Cancer Res. – volume: 84 start-page: 549 year: 2006 end-page: 558 article-title: Structure and function of nucleosome assembly proteins publication-title: Biochem. Cell Biol. – volume: 151 start-page: 52 year: 2015 end-page: 65 article-title: The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1) publication-title: J. Steroid Biochem. Mol. Biol. – year: 2003 – volume: 20 start-page: 324 year: 2003 end-page: 327 article-title: Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco‐2 and human colorectal cancer cell lines publication-title: Pharm. Res. – volume: 15 start-page: 57 year: 2001 end-page: 68 article-title: Expression profiles of SF‐1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation publication-title: Mol. Endocrinol. – volume: 63 start-page: 3546 year: 2003 end-page: 3555 article-title: Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha publication-title: Cancer Res. – volume: 121 start-page: 86 year: 2011 end-page: 95 article-title: Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis publication-title: J. Clin. Invest. – volume: 66 start-page: 7490 year: 2006 end-page: 7501 article-title: Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation‐mediated silencing in malignant glioma publication-title: Cancer Res. – volume: 13 start-page: 1 year: 2008 end-page: 18 article-title: Steroidogenic enzymes publication-title: Endocr. Dev. – year: 2016 – volume: 104 start-page: 1 year: 1995 end-page: 8 article-title: Substrates of human hepatic cytochrome P450 3A4 publication-title: Toxicology – volume: 67 start-page: 451 year: 2000 end-page: 457 article-title: St John's Wort: effect on CYP3A4 activity publication-title: Clin. Pharmacol. Ther. – volume: 518 start-page: 422 year: 2015 end-page: 426 article-title: Dynamics of genomic clones in breast cancer patient xenografts at single‐cell resolution publication-title: Nature – volume: 168 start-page: 66 year: 2007 end-page: 73 article-title: The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics publication-title: Chem. Biol. Interact. – volume: 78 start-page: 1361 year: 1998 end-page: 1367 article-title: Expression in human prostate of drug‐ and carcinogen‐metabolizing enzymes: association with prostate cancer risk publication-title: Br. J. Cancer – volume: 67 start-page: 5033 year: 2007 end-page: 5041 article-title: Intraprostatic androgens and androgen‐regulated gene expression persist after testosterone suppression: therapeutic implications for castration‐resistant prostate cancer publication-title: Cancer Res. – volume: 25 start-page: 343 year: 2010 end-page: 350 article-title: Effects of CYP2C9*3 and CYP2C9*13 on diclofenac metabolism and inhibition‐based drug‐drug interactions publication-title: Drug Metab. Pharmacokinet. – volume: 44 start-page: 1310 year: 2012 end-page: 1315 article-title: Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin‐remodeling and ubiquitin ligase complex genes publication-title: Nat. Genet. – volume: 24 start-page: 1024 year: 2010 end-page: 1036 article-title: FOXL2 interacts with steroidogenic factor‐1 (SF‐1) and represses SF‐1‐induced CYP17 transcription in granulosa cells publication-title: Mol. Endocrinol. – volume: 308 start-page: 495 year: 2004 end-page: 501 article-title: Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor publication-title: J. Pharmacol. Exp. Ther. – volume: 71 start-page: 6503 year: 2011 end-page: 6513 article-title: Intratumoral de novo steroid synthesis activates androgen receptor in castration‐resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors publication-title: Cancer Res. – volume: 364 start-page: 54 year: 2012 end-page: 64 article-title: Regulation of CYP3A4 and CYP3A5 expression and modulation of “intracrine” metabolism of androgens in prostate cells by liganded vitamin D receptor publication-title: Mol. Cell. Endocrinol. |
| SSID | ssj0004988 |
| Score | 2.419671 |
| Snippet | The testis‐specific Y‐encoded‐like protein (TSPYL) gene family includes TSPYL1 to TSPYL6. We previously reported that TSPYL5 regulates cytochrome P450 (CYP)... The testis-specific Y-encoded-like protein (TSPYL) gene family includes TSPYL1 to TSPYL6. We previously reported that TSPYL5 regulates cytochrome P450 (CYP)... |
| SourceID | proquest pubmed wiley |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 201 |
| SubjectTerms | Abiraterone Acetate - pharmacology Abiraterone Acetate - therapeutic use Cell Cycle Proteins - drug effects Cell Cycle Proteins - genetics Cell Proliferation - drug effects Cell Proliferation - genetics Cytochrome P-450 CYP3A - drug effects Cytochrome P-450 CYP3A - genetics Cytochrome P-450 CYP3A - metabolism Cytochrome P-450 Enzyme Inhibitors - pharmacology Cytochrome P-450 Enzyme Inhibitors - therapeutic use Dehydroepiandrosterone - metabolism Gene Expression Regulation - drug effects Gene Knockdown Techniques Hep G2 Cells Humans Male Neoplasm Metastasis Nuclear Proteins - drug effects Nuclear Proteins - genetics Proportional Hazards Models Prostatic Neoplasms, Castration-Resistant - drug therapy Prostatic Neoplasms, Castration-Resistant - pathology RNA, Messenger - metabolism Steroid 17-alpha-Hydroxylase - antagonists & inhibitors Steroid 17-alpha-Hydroxylase - drug effects Steroid 17-alpha-Hydroxylase - genetics Treatment Outcome |
| Title | TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcpt.907 https://www.ncbi.nlm.nih.gov/pubmed/29027195 https://www.proquest.com/docview/1951570310 |
| Volume | 104 |
| WOSCitedRecordID | wos000434960300035&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBYl7aGXvh_bF1MIOcWN9diV1NuyJPTQLKLdwuZkJFkOe6g2rJ3S3PIT8h_6z_JLMrJ2sy30UOhFNkhjC2ZkfWPNfEPI7rC0QaFlFE3Nm0LgHlIoK3ghNKuFFUIyb_tiE3I6VfO5Nr-V-sr8ELc_3NLK6L_XaYFb1x5sSUP9WfdBpzzyu5RymQyaCbNNidRKbYqoIYYZ5XzZJHqwFvwbpPwTofZbzNHD_5jcI_JgjSthnA3hMbkT4hOyZzIx9cU-zLZ5Vu0-7IHZUlZfPCW_Zl_NyWfIVTDgS65PH1qYnBgqxxRsrNM9Hws4_LkOnY0fwSy7FGyE7z0OKYN40X6HRHeVi2jFU-iWMHbpJD-sljHgg_uA3ACLiBKdTdlMCw8TuyHvvb68wjEJ0sYOTEpIQVHsR8tcPSPfjg5nk0_FunxD4XHHk0XDat8E5ijz3tHkKzVDJkutvGXSo6MmnObaDYXVuFOPuHNOyxohE3OqEdLx52Qn4uReEig1b5hHz9JLLmqUUzV1gdbW2VHp1GhA3m90WeHySGceNobleVtRRJCJZIyWA_IiK7k6yzweFdPok-OAAdntdXnbkamcWYVarFCL1cTM8PLq34a9JvcRVKkc0vuG7HSr8_CW3PM_ukW7etdbKbZyrrCdmuMbR6TwGg |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NatwwEBYlDbSXtulftumPCiGnuLFl7UrqbVkSUrpZROtCcjKSLJc9RBvWTmlueYS8Q96sT9IZy5ul0EOhJxussQUz8nwjzXxDyO4wNV6CZSR1ldcJBx-SSMPzhCtWccO5YM50zSbEbCZPT5XusyqxFibyQ9xtuOHK6P7XuMBxQ_pgzRrqLtoPCgvJ73PwMdi9gHG9rolUUq66qAGIGcWCWRQ96AX_hin_hKidjzl6_D-ze0Ie9ciSjqMpbJF7PjwlezpSU1_t02JdadXs0z2q16TVV8_IbfFVn01p7INBv8QO9b6hkzOdiXFGTajwPh9zevizT54NH6letJhuBN898VhDPG_OKRJexTZa4TttF3Rs8SzfLxfBw4u7lFxP5wEkWoP1THNHJ2ZF3_vr-gbGIKgNLdVYkgKi8Bxsc_mcfDs6LCbHSd_AIXHg80RSs8rVntmMOWczjJbqIROpks4w4SBU41blyg65UeCrR7m1VokKQBOzsubC5i_IRoDJbROaqrxmDmJLJ3JegZysMuuzylgzSq0cDcj7lTJLWCB46mGCX1w2ZQYYEmnGsnRAXkYtlxeRyaNkCqJyGDAgu50y7x5EMmdWghZL0GI50QVcXv3bsHfkwXFxMi2nn2afd8hDgFgyJvi-Jhvt8tK_IZvuRztvlm87k_0NJqzyCA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELZQQYhL-W-X30Gqempo4njXNrfV0hWIsrJgkdpT5L-gPeBdbVJEbzwC78Cb8SSM42xXSByQOCVSPImlGXtm4vm-IeRgmGsv0DKy2pV1xtCHZEKzMmOSOqYZ49TqrtkEn83E2ZlUfVVlxMIkfoirH25xZXT7dVzgfuXq4y1rqF21L2UEkl9nQ9xhI6szU1tMpBRi00UNg5hRAsxG0eNe8G8x5Z8haudjprf_Z3Z3yG4fWcI4mcJdcs2He-RQJWrqyyOYb5FWzREcgtqSVl_eJz_nH9X5KaQ-GPAhdaj3DUzOVcHHBejg4n05ZnDyrS-eDa9ALdtYboTffe8jhnjRfIFIeJXaaIXP0C5hbOJZvl8vg8cXdyW5HhYBJVod8UwLCxO9oe_99f0HjolBbWhBRUgKiuJztM31A_JpejKfvMn6Bg6ZRZ_Hs5o6W3tqCmqtKWK2VA8pz6WwmnKLqRozspRmyLREXz0qjTGSOwyaqBE146Z8SHYCTm6fQC7LmlrMLS0vmUM54QrjC6eNHuVGjAbkxUaZFS6QeOqhg19eNFWBMWSkGSvyAdlLWq5WicmjohKzchwwIAedMq8eJDJnWqEWK9RiNVFzvDz6t2HPyU31elqdvp29e0xuYYQlUn3vE7LTri_8U3LDfm0XzfpZZ7G_AeAr8Yw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TSPYL+Family+Regulates+CYP17A1+and+CYP3A4+Expression%3A+Potential+Mechanism+Contributing+to+Abiraterone+Response+in+Metastatic+Castration%E2%80%90Resistant+Prostate+Cancer&rft.jtitle=Clinical+pharmacology+and+therapeutics&rft.au=Qin%2C+Sisi&rft.au=Liu%2C+Duan&rft.au=Kohli%2C+Manish&rft.au=Wang%2C+Liguo&rft.date=2018-07-01&rft.issn=0009-9236&rft.eissn=1532-6535&rft.volume=104&rft.issue=1&rft.spage=201&rft.epage=210&rft_id=info:doi/10.1002%2Fcpt.907&rft.externalDBID=10.1002%252Fcpt.907&rft.externalDocID=CPT907 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9236&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9236&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9236&client=summon |